SEC 13F Intelligence

Ceeto Capital Group, LLC / ABBV

Ceeto Capital Group, LLC’s Abbvie Inc Position

Does Ceeto Capital Group, LLC own Abbvie Inc (ABBV)? Yes — 20.3K shares worth $4M (+1.35% of its 13F portfolio) as of Q1 2026, up from 19.5K shares the prior filed quarter.

Position Value
$4M
Q1 2026
Shares
20.3K
% of Portfolio
+1.35%
Quarters Held
30
currently held

Position History ABBV

Reported value by quarter
Q4 ’18: $2MQ4 ’18Q1 ’19: $1MQ2 ’19: $1MQ3 ’19: $1MQ4 ’19: $2MQ4 ’19Q1 ’20: $2MQ2 ’20: $2MQ3 ’20: $2MQ4 ’20: $3MQ4 ’20Q1 ’21: $3MQ2 ’21: $3MQ3 ’21: $2MQ4 ’21: $3MQ4 ’21Q1 ’22: $3MQ2 ’22: $3MQ3 ’22: $3MQ4 ’22: $3MQ4 ’22Q1 ’23: $3MQ2 ’23: $3MQ3 ’23: $3MQ4 ’23: $3MQ4 ’23Q1 ’24: $4MQ2 ’24: $4MQ3 ’24: $4MQ4 ’24: $3MQ4 ’24Q1 ’25: $4MQ2 ’25: $4MQ3 ’25: $5MQ4 ’25: $4MQ4 ’25Q1 ’26: $4Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 202620.3K$4M+1.35%
Q4 202519.5K$4M+1.30%
Q3 202519.5K$5M+1.31%
Q2 202519.5K$4M+1.26%
Q1 202519.1K$4M+1.52%
Q4 202419.1K$3M+1.25%
Q3 202418.9K$4M+1.39%
Q2 202420.7K$4M+1.37%
Q1 202420.7K$4M+1.54%
Q4 202320.6K$3M+1.37%
Q3 202320.6K$3M+1.49%
Q2 202318.9K$3M+1.17%
Q1 202318.9K$3M+1.50%
Q4 202218.9K$3M+1.68%
Q3 202218.8K$3M+1.45%
Q2 202218.8K$3M+1.58%
Q1 202218.8K$3M+1.39%
Q4 202119.3K$3M+1.09%
Q3 202119.3K$2M+0.97%
Q2 202125.8K$3M+1.31%
Q1 202125.8K$3M+1.36%
Q4 202025.6K$3M+1.38%
Q3 202024.9K$2M+1.22%
Q2 202021.8K$2M+1.38%
Q1 202019.9K$2M+1.22%
Q4 201919.0K$2M+1.10%
Q3 201919.0K$1M+1.04%
Q2 201920.0K$1M+1.07%
Q1 201918.0K$1M+1.06%
Q4 201817.5K$2M+1.33%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Ceeto Capital Group, LLC’s full portfolio or all institutional holders of ABBV.